Law ❯ Litigation ❯ Class Action ❯ Securities Class Action

Investor Rights

Gossamer Bio Investors Face June 1 Deadline to Seek Lead Role in Securities Class Action

Plaintiffs allege the company misled the market about placebo handling in its Phase 3 PROSERA trial at Latin American sites.

Super Micro Investors Face May 26 Deadline to Seek Lead Role in Securities Suits

Oddity Tech Investors Face Monday Deadline To Seek Lead Role in Securities Case

Super Micro Investors Face Late-May Deadlines in Securities Class Actions Over China Sales Allegations

Rosen Law Firm Reminds PSIX Investors of May 19 Deadline to Seek Lead Plaintiff Role

Law Firms Urge NUAI Investors Ahead of June 1 Lead‑Plaintiff Deadline in Securities Suit

Class Action Filed Against Atara Biotherapeutics Over Alleged Misstatements on FDA Setbacks

LKQ Faces Securities Class Action Over FinishMaster Deal and Disclosures

Gossamer Bio Investors Face June 1 Deadline in Securities Class Action

Pomerantz Files Securities Class Action Against Nektar Over REZOLVE‑AA Trial Disclosures

Eos Energy Investors Face May 5 Deadline to Seek Lead Role in Securities Case

Nektar Securities Suit Urges Investors To Seek Lead‑Plaintiff Status Before May 5

Corcept Investors Face Today’s Lead‑Plaintiff Deadline in Securities Case Over Relacorilant Disclosures

Driven Brands Investors Urged to Seek Lead Role in Securities Suit Before May 8

Super Micro Investors Sought to Lead Securities Suits After DOJ Export-Control Indictment

Navan IPO Investors Urged to Seek Lead Role in Class Action Before April 24

Law Firms Court Pinterest Investors to Lead Securities Suit Before May 29 Deadline

Concorde Investors Urged to Seek Lead Plaintiff by May 20 in Securities Suit

Boston Scientific Investors Urged to Seek Lead Plaintiff Role in Securities Suit

Atara Biotherapeutics Hit With Investor Class Action as Firms Press May 22 Lead-Plaintiff Deadline